Novartis AG

OTC: NVSEF · Real-Time Price · USD
120.78
5.28 (4.57%)
At close: Aug 15, 2025, 1:24 PM

Novartis Income Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
14.84B 13.62B 13.56B 13.17B 12.59B 11.46B 11.78B 12.09B 13.94B 13.21B 13.09B 12.84B 13.09B 12.81B 13.52B 13.37B 13.29B 12.69B
Cost of Revenue
3.32B 3.23B 3.32B 3.23B 3.24B 3.03B 3.02B 3.12B 4.34B 3.93B 4.07B 3.81B 3.75B 3.86B 3.98B 3.94B 3.91B 4.04B
Gross Profit
11.51B 10.39B 10.23B 9.94B 9.35B 8.43B 8.75B 8.97B 9.6B 9.28B 9.01B 9.04B 9.33B 8.96B 9.55B 9.43B 9.38B 8.65B
Operating Income
4.86B 4.65B 3.53B 3.63B 3.95B 3.52B 2.58B 1.76B 2.92B 2.86B 1.95B 2.17B 2.23B 2.85B 2.56B 3.23B 3.48B 2.42B
Interest Income
n/a n/a 291M 26M 75M 6M n/a 7.25M 75M 104M n/a n/a 16M 20M n/a n/a n/a n/a
Pretax Income
4.53B 4.48B 3.29B 3.38B 3.87B 3.06B 2.38B 1.55B 2.77B 2.74B 1.74B 1.92B 2.04B 2.67B 16.95B 3.23B 3.51B 2.45B
Net Income
4.04B 3.66B 2.82B 3.19B 3.25B 2.69B 8.48B 1.76B 2.32B 2.29B 1.47B 1.57B 1.69B 2.22B 16.31B 2.76B 2.9B 2.06B
Selling & General & Admin
3.44B 3.06B 3.5B 3.13B 3.11B 2.75B 3.44B 3.09B 3.69B 3.44B 3.75B 3.41B 3.58B 3.51B 3.98B 3.62B 3.75B 3.53B
Research & Development
2.73B 2.37B 2.84B 2.39B 2.29B 2.16B 2.57B 3.92B 2.53B 2.79B 2.44B 2.74B 2.5B 2.32B 2.41B 2.38B 2.4B 2.35B
Other Expenses
481M 306M 361M 785M n/a n/a n/a n/a n/a n/a 35.45M 28.39M 72.68M 67.04M 2.02M 75.8M 96.52M n/a
Operating Expenses
6.65B 5.73B 6.7B 6.31B 5.4B 4.91B 6.17B 7.21B 6.67B 6.42B 7.07B 6.87B 7.11B 6.11B 6.98B 6.2B 5.9B 6.24B
Interest Expense
300.86M 274.19M 275M 264M 246M 221M 217M 222M 224M 200M 219M 206M 202M 201M 135M 202M 201M 202M
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
9.97B 8.96B 10.03B 9.54B 8.64B 7.95B 9.19B 10.33B 11.02B 10.35B 11.14B 10.67B 10.86B 9.96B 10.96B 10.13B 9.81B 10.28B
Income Tax Expense
507M 810.37M 465M 200M 598.61M 427.43M -261M 39M 452M 446M 275M 344M 347M 450M 645M 472M 611M 391M
Shares Outstanding (Basic)
1.95B 1.97B 1.99B 2.01B 2.03B 2.04B 2.05B 2.06B 2.08B 2.11B 2.13B 2.17B 2.2B 2.23B 2.24B 2.24B 2.24B 2.25B
Shares Outstanding (Diluted)
1.96B 1.98B 2B 2.03B 2.05B 2.06B 2.06B 2.08B 2.1B 2.12B 2.15B 2.18B 2.21B 2.24B 2.25B 2.25B 2.26B 2.27B
EPS (Basic)
2.07 1.83 1.42 1.58 1.61 1.27 4.36 0.82 1.12 1.10 0.72 0.73 0.77 1.00 7.29 1.23 1.29 0.91
EPS (Diluted)
2.06 1.82 1.41 1.57 1.60 1.27 4.33 0.82 1.11 1.09 0.71 0.72 0.77 0.99 7.24 1.22 1.28 0.91
EBITDA
6.08B 5.83B 5.19B 5.61B 5.12B 4.55B 4.43B 4.88B 4.82B 4.59B 4.08B 4.08B 4.08B 4.28B 18.68B 4.59B 4.84B 4.35B
EBIT
4.82B 4.68B 3.56B 3.65B 4.09B 3.27B 2.76B 1.77B 2.89B 2.72B 2.05B 2.09B 2.27B 2.87B 17.16B 3.16B 3.42B 2.65B
Depreciation & Amortization
1.26B 1.15B 1.63B 1.97B 1.17B 1.27B 1.67B 3B 1.83B 2.02B 2.03B 1.98B 1.82B 1.41B 1.53B 1.43B 1.42B 1.7B